Both funding and downstream processing deals confirm the premier nature of this resource. Demand is now leading to the planning of stage 3 which will likewise be funded by Posco. The Australian dollar briefly touched USD0.68, a ten year low. As far as i can see, we will be printing money for the next 10 years. A pretty sweet deal if you ask me.
If i were you however, I'd be looking at your other lithium holding. No funding, land locked with still no definite transport route. People over there were suggesting they'd be mining this year which i found laughable and said as much. As credit market becomes tighter, explorers such as your holding will find it tough to continue the grind to develop the resource. The current SP would make the upcoming CR heavily dilutive as well. More than enough to worry about over there mate.
Good luck. You guys will need it. I'll stick with PLS. Australia's and perhaps the world's most promising lithium miner.
- Forums
- ASX - By Stock
- PLS
- Ann: Funding Package for Stage 2 Pilgangoora Expansion
Ann: Funding Package for Stage 2 Pilgangoora Expansion, page-123
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PLS (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.13 |
Change
0.170(5.74%) |
Mkt cap ! $9.425B |
Open | High | Low | Value | Volume |
$3.05 | $3.14 | $3.01 | $78.76M | 25.44M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1050 | $3.12 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.14 | 385402 | 22 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1050 | 3.120 |
2 | 14848 | 3.110 |
12 | 255876 | 3.100 |
15 | 1471406 | 3.080 |
5 | 153212 | 3.070 |
Price($) | Vol. | No. |
---|---|---|
3.140 | 338319 | 20 |
3.150 | 546670 | 74 |
3.160 | 137443 | 15 |
3.170 | 26176 | 10 |
3.180 | 123346 | 17 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
PLS (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online